Company intelligence / Profile preview

Atlas Biomed

London, United Kingdom

Ownership: Private
Development stage: Commercial

Overview

Atlas Biomed offers personalized genetic and microbiome tests that provide users with insights into disease risk management, nutrition response, ancestry, and gut health. The reports include color-coded risk assessments for conditions like type 2 diabetes and offer actionable lifestyle recommendations based on genetic data. The platform is designed to encourage preventative rather than reactive healthcare solutions.

Modalities: Genetic testMicrobiome test
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on Atlas Biomed.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atlas Biomed.

Explore the full profile